Company Registration No. 11646228 (England and Wales)
ZEYMOS PHARMA LTD
Unaudited accounts
for the year ended 31 March 2025
ZEYMOS PHARMA LTD
Unaudited accounts
Contents
ZEYMOS PHARMA LTD
Company Information
for the year ended 31 March 2025
Directors
Dr Zeyad Almthqal
Sabri Musa Bein
Company Number
11646228 (England and Wales)
Registered Office
UNIT 19 , METRO CENTER
BRITANNIA WAY
LONDON
NW10 7PA
ENGLAND
Accountants
Yahya & Co Accountants Ltd
T/A Yahya Accountancy
164 West Hendon Broadway
London
NW9 7AA
ZEYMOS PHARMA LTD
Statement of financial position
as at 31 March 2025
Tangible assets
142,157
169,666
Inventories
46,699
250,045
Cash at bank and in hand
19,229
584,792
Creditors: amounts falling due within one year
(67,869)
(348,445)
Net current assets
178,771
149,720
Total assets less current liabilities
320,928
319,386
Creditors: amounts falling due after more than one year
(247,543)
(260,140)
Called up share capital
1
1
Profit and loss account
73,384
59,245
Shareholders' funds
73,385
59,246
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 22 December 2025 and were signed on its behalf by
Sabri Musa Bein
Director
Company Registration No. 11646228
ZEYMOS PHARMA LTD
Notes to the Accounts
for the year ended 31 March 2025
ZEYMOS PHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 11646228. The registered office is UNIT 19 , METRO CENTER, BRITANNIA WAY, LONDON, NW10 7PA, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
10% Reducing Balance Method
Fixtures & fittings
10% Reducing Balance Method
Computer equipment
18% Reducing Balance Method
4
Tangible fixed assets
Plant & machinery
Motor vehicles
Fixtures & fittings
Computer equipment
Total
Cost or valuation
At cost
At cost
At cost
At cost
At 1 April 2024
15,160
163,880
32,801
6,341
218,182
Additions
3,695
-
-
-
3,695
At 31 March 2025
18,855
163,880
32,801
6,341
221,877
At 1 April 2024
5,176
29,498
11,280
2,562
48,516
Charge for the year
2,462
24,188
3,874
680
31,204
At 31 March 2025
7,638
53,686
15,154
3,242
79,720
At 31 March 2025
11,217
110,194
17,647
3,099
142,157
At 31 March 2024
9,984
134,382
21,521
3,779
169,666
ZEYMOS PHARMA LTD
Notes to the Accounts
for the year ended 31 March 2025
Amounts falling due within one year
Trade debtors
107,249
(378,681)
Amounts falling due after more than one year
Other debtors
60,085
10,000
6
Creditors: amounts falling due within one year
2025
2024
Bank loans and overdrafts
5,556
5,556
Obligations under finance leases and hire purchase contracts
23,720
24,409
Trade creditors
(24,736)
285,622
Taxes and social security
48,953
31,401
7
Creditors: amounts falling due after more than one year
2025
2024
Obligations under finance leases and hire purchase contracts
74,572
97,603
Loans from directors
147,502
131,513
8
Average number of employees
During the year the average number of employees was 8 (2024: 7).